Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.555
-0.155 (-9.06%)
Aug 14, 2025, 2:01 PM - Market open
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $142.23 million as of August 14, 2025. Its market cap has decreased by -58.39% in one year.
Market Cap
142.23M
Enterprise Value
-26.19M
1-Year Change
-58.39%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has decreased from $235.53M to $142.23M, a decrease of -39.61%. That is a compound annual growth rate of -8.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 156.41M | 40.97% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | 300.21M | -10.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |